CID is 150311
synonyms found at PubChem are:
Ezetimibe, 163222-33-1, Zetia, Ezetrol, Ezedoc, ezetimib, Sch 58235, SCH-58235, (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one, Zient, Ezetimibe [USAN:INN], UNII-EOR26LQQ24, SCH58235, (-)-Sch 58235, Ezetimibe (Zetia), Zetia (TN), EOR26LQQ24, Ezetimibe (JAN/USAN/INN), CHEBI:49040, 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone, MK-0653, DSSTox_CID_24223, DSSTox_RID_80127, DSSTox_GSID_44223, (3R,4S)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one, (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone, 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione, (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)azetidin-2-one, 2-Azetidinone, 1-(4-fluorophenyl)-3-((3S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-, (3R,4S)-, 2-Azetidinone, 1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-, (3R-(3alpha(S*),4beta))-, SMR000466334, CAS-163222-33-1, MSD brand of ezetimibe, Essex brand of ezetimibe, Merck brand of ezetimibe, ezentia, ezetimiba, ezetimibum, Ezetimibe [USAN:INN:BAN], Zetia ;Ezetrol, C24H21F2NO3, HSDB 7737, Schering-Plough brand of ezetimibe, NCGC00095134-01, 2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-, Vytorin (TN), Inegy (TN), D09LWS, SCHEMBL2871, Zetia , Ezetrol, Ezetimibe, CHEMBL1138, MLS000759443, MLS001424125, MLS006011921, AC1L442L, GTPL6816, DTXSID1044223, Ezetimibe, >=98% (HPLC), EX-A795, MolPort-005-938-627, OLNTVTPDXPETLC-XPWALMASSA-N, HMS2051K16, HMS2236A04, HMS3715D06, ACT03511, AMX10142, ZINC3810860, Tox21_111443, ABP001091, BDBM50371521, s1655, STK640490, AKOS005572111, Tox21_111443_1, AC-1057, AM84560, AN-5188, CCG-100884, CS-1016, DB00973, KS-1170, MCULE-4417284526, NC00134, RL02093, NCGC00263575-01, NCGC00263575-07, (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone), BC216471, CPD000466334, HY-17376, SAM001246623, SC-17354, AB0011316, AB2000199, LS-181801, FT-0601590, D01966, K-5098, 28055-EP2272841A1, 28055-EP2280001A1, 28055-EP2287165A2, 28055-EP2287166A2, 28055-EP2292620A2, 28055-EP2294052A1, 28055-EP2295422A2, 28055-EP2298742A1, 28055-EP2298769A1, 28055-EP2298776A1, 28055-EP2301923A1, 28055-EP2301936A1, 28055-EP2308878A2, 28055-EP2314588A1, AB00639916-06, AB00639916-08, AB00639916_09, 222E331, 3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one, BRD-K42260897-001-09-2, Z1550648770, (3R,4S)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-, Ezetimibe, United States Pharmacopeia (USP) Reference Standard, Ezetimibe, Pharmaceutical Secondary Standard; Certified Reference Material, (3R,4S)-1-(4-fluorophenyl)-3-[(3 S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one, (3R,4S)-1-(4-Fluorophenyl)-3-[(S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-azetidin-2-one